Stock Analysis on Net

Ecolab Inc. (NYSE:ECL)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 25, 2022.

Return on Equity (ROE)
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Ecolab Inc., ROE, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands


Net Income Trends
The net income attributable to the company demonstrates an overall growth trajectory from 2005 through 2019, rising from approximately 319 million USD to a peak near 1.56 billion USD in 2019. A significant drop occurred in 2020, resulting in a net loss of around 1.21 billion USD, followed by a recovery in 2021 with net income reaching approximately 1.13 billion USD. This sharp loss in 2020 contrasts with the steady increases seen in prior years and indicates an unusual or one-time event impacting that fiscal year.
Total Shareholders’ Equity
Total equity generally increased from about 1.65 billion USD in 2005 to over 8.68 billion USD in 2019, reflecting considerable growth in the company's net worth over this period. However, a notable decline is apparent in 2020, when equity dropped to approximately 6.17 billion USD, followed by a partial rebound to roughly 7.22 billion USD in 2021. The decrease in equity during 2020 corresponds with the net loss recorded that year, suggesting a significant financial impact affecting shareholder value.
Return on Equity (ROE)
ROE shows positive values throughout most of the period, signaling profitability relative to shareholders’ equity. Starting at 19.37% in 2005, ROE fluctuates with a low of 8.16% in 2011 and peaks above 28% in 2008, demonstrating variability in returns. After 2011, it trends upward again reaching approximately 19.8% in 2017 before slightly declining to around 17.95% in 2019. A drastic reversal occurs in 2020, with ROE plunging to -19.54%, consistent with the net loss and reduced equity in that year. In 2021, ROE rebounds to a positive level near 15.64%, aligning with the recovery in net income and equity.
Overall Financial Patterns
From 2005 to 2019, all key financial metrics—net income, shareholders’ equity, and ROE—reflect steady growth and healthy profitability, although some intermediate volatility is observed. The 2020 fiscal year constitutes a significant disruption marked by a large net loss, a contraction in equity, and a negative ROE, indicating severe operational or market challenges. The subsequent improvement in 2021 suggests resilience and a return towards previous financial performance levels. This pattern may warrant further analysis to identify underlying causes and to assess the sustainability of the recent recovery.

Comparison to Competitors


Comparison to Sector (Chemicals)


Comparison to Industry (Materials)